Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine
- PMID: 2295215
- DOI: 10.1038/clpt.1990.3
Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine
Abstract
The interactions between digoxin and quinine and quinidine that affect the renal and biliary clearances of digoxin were investigated in eight healthy subjects. Digoxin (0.5 to 0.75 mg/day) was given alone and with concomitant administration of quinine (750 mg/day) to reach a steady-state level. In four of the subjects, the study was repeated by administration of equimolar doses of the diastereoisomer quinidine together with digoxin, enabling a within-subject comparison of the effects of the two isomers on digoxin clearance. The biliary excretion of digoxin was studied by use of a modified duodenal marker perfusion technique. A marked reduction was found in the steady-state biliary clearance of digoxin from control value 134 +/- 57 ml/min (mean +/- SD) to 87 +/- 39 ml/min during treatment with quinine (p less than 0.05) and from 95 +/- 24 to 55 +/- 27 ml/min during treatment with quinidine (p less than 0.01; n = 4). Quinidine reduced the renal clearance of digoxin (155 +/- 26 versus 110 +/- 21 ml/min) (p less than 0.05; n = 4), whereas quinine had no such effect (177 +/- 40 versus 185 +/- 53 ml/min; not significant). These findings explain the difference in magnitude between quinidine and quinine in regard to the interaction with digoxin and imply a different degree of stereoselectivity for these isomers in the renal and biliary secretory systems of digoxin.
Similar articles
-
The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides.J Hepatol. 1998 Feb;28(2):240-9. doi: 10.1016/0168-8278(88)80011-4. J Hepatol. 1998. PMID: 9514537
-
Quinidine reduces biliary clearance of digoxin in man.Eur J Clin Invest. 1987 Jun;17(3):262-5. doi: 10.1111/j.1365-2362.1987.tb01246.x. Eur J Clin Invest. 1987. PMID: 3113970
-
Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.J Pharm Sci. 1998 Apr;87(4):457-61. doi: 10.1021/js970334v. J Pharm Sci. 1998. PMID: 9548899
-
Quinidine and digoxin. An important interaction.Drugs. 1982 Sep;24(3):229-39. doi: 10.2165/00003495-198224030-00003. Drugs. 1982. PMID: 6751790 Review.
-
Current status of cardiac glycoside drug interactions.Clin Pharm. 1985 Jul-Aug;4(4):404-13. Clin Pharm. 1985. PMID: 2412751 Review.
Cited by
-
Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.Eur J Clin Pharmacol. 1992;42(5):481-5. doi: 10.1007/BF00314854. Eur J Clin Pharmacol. 1992. PMID: 1606994 Clinical Trial.
-
No effect of probenecid on the renal and biliary clearances of digoxin in man.Br J Clin Pharmacol. 1991 Jul;32(1):63-7. doi: 10.1111/j.1365-2125.1991.tb05614.x. Br J Clin Pharmacol. 1991. PMID: 1888643 Free PMC article.
-
Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.Drugs. 2017 May;77(8):859-883. doi: 10.1007/s40265-017-0729-x. Drugs. 2017. PMID: 28382570 Review.
-
Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.Eur J Clin Pharmacol. 1991;41(5):471-4. doi: 10.1007/BF00626372. Eur J Clin Pharmacol. 1991. PMID: 1761076
-
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.Clin Pharmacokinet. 2003;42(15):1359-82. doi: 10.2165/00003088-200342150-00004. Clin Pharmacokinet. 2003. PMID: 14674788 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources